Learn More
Medchemexpress LLC Ertugliflozin L-pyroglutamic acid | 1210344-83-4 | 99.8% | 566.00 | 5 MG

Supplier: Medchemexpress LLC 5MGHY15461A
Ertugliflozin L-pyroglutamic acid is a potent, selective, and orally active inhibitor of the sodium-dependent glucose cotransporter 2 (SGLT2), with an IC50 of 0.877 nM for h-SGLT2. It has potential for the treatment of type 2 diabetes mellitus.
- Potent, selective, and orally active inhibitor of the sodium-dependent glucose cotransporter 2 (SGLT2)
- Potential for the treatment of type 2 diabetes mellitus
- Demonstrates >2000-fold selectivity for SGLT2 inhibition (relative to SGLT1) in vitro
- Reveals a concentration-dependent glucosuria after oral administration to rats
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.